(Press-News.org) In patients with newly diagnosed tuberculosis (TB), use of a combined 4-drug fixed-dose regimen was found to have comparable outcomes to drugs administered separately, according to a study in the April 13 issue of JAMA, a theme issue on infectious disease and immunology.
Christian Lienhardt, M.D., M.Sc., Ph.D., of the World Health Organization, Geneva, Switzerland, presented the findings of the study at a JAMA media briefing at the National Press Club. Dr. Lienhardt conducted the study while heading the Clinical Trial Division at the International Union Against Tuberculosis and Lung Disease.
"Despite the availability of a highly effective 6-month chemotherapy regimen, worldwide control of tuberculosis is severely impeded by poor treatment completion rates that threaten the emergence of multidrug resistance," according to background information in the article. "Fixed-dose combinations (FDCs) of drugs have been advocated as a way of preventing the emergence of drug resistance attributable to inappropriate drug intake. In addition, they can reduce the risk of incorrect dosage, simplify drug procurement, and aid in ensuring adherence."
Dr. Lienhardt and colleagues conducted a multicenter randomized controlled trial to evaluate the efficacy and safety of a 4-drug FDC for the treatment of tuberculosis. The study was conducted at 11 sites in Africa, Asia, and Latin America between 2003 and 2008 and included 1,585 adult patients with newly diagnosed smear-positive pulmonary tuberculosis. Patients were randomized to receive daily treatment with 4 drugs (rifampicin, isoniazid, pyrazinamide, ethambutol) given as an FDC (n = 798 patients) or separately (n = 787) in the 8-week intensive phase of treatment. A favorable treatment outcome was defined as a negative culture result at 18 months post randomization and not having already been classified as unfavorable. The FDC was assessed for noninferiority (no worse than the separate drug regimen) via several measures.
The researchers found that, in the per-protocol analysis 18 months after the start of treatment, 555 of 591 patients (93.9 percent) in the FDC group vs. 548 of 579 (94.6 percent) in the separate-drugs group had a favorable outcome. In two different models of a modified intention to treat analysis, the researchers found that 570 of 684 patients (83.3 percent) in the FDC group had a favorable outcome, compared with 563 of 664 (84.8 percent) in the separate-drugs group; and 591 of 658 assessable patients (89.8 percent) in the FDC group had a favorable outcome, compared with 589 of 647 (91.0 percent) in the separate-drugs group, respectively.
"The results of this trial show, using a strict definition of noninferiority, that a 4-drug FDC regimen may be noninferior to a regimen of separately administered drugs in terms of efficacy for treatment of tuberculosis," the researchers write. They add that one of the main advantages of FDCs is that patients have to take considerably fewer pills (3-4 instead of 9-16 per day in the intensive phase), thus making treatment easier, aiding adherence, and potentially eliminating the risk of developing drug resistance attributable to selective drug intake.
"FDCs are a full part of the recently revised World Health Organization treatment guidelines. The uptake of FDCs in tuberculosis control programs globally is gaining momentum, but challenges remain," the authors write. "The uptake and acceptance of FDCs is primarily affected by doubts about the efficacy of FDCs, questions of access and quality, advantages over other formulations or packaging, lack of political will at the country level, and the conflicting policies of funders."
"For efficient tuberculosis control worldwide, it is essential that quality-assured FDCs are made available. While new regimens or drugs are being developed for the treatment of tuberculosis, it is essential that strategies are developed for their introduction in national tuberculosis control programs, which includes the protection of these new drugs within established and quality-assured FDCs."
###
(JAMA. 2011;305[14]1415-1423. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact Christian Lienhardt, M.D., M.Sc., Ph.D., email lienhardtc@who.int.
END
Administration of human papillomavirus (HPV) vaccine doses over a longer period of time to adolescent girls in Vietnam resulted in antibody concentration levels that were comparable to the standard vaccine schedule, according to a study in the April 13 issue of JAMA, a theme issue on infectious disease and immunology.
Kathleen M. Neuzil, M.D., M.P.H., of PATH, Seattle, presented the findings of the study at a JAMA media briefing at the National Press Club in Washington, D.C.
Cervical cancer is an important cause of illness and death among women throughout the world. ...
Over on Facebook we're giving away a free iPad to one lucky winner as soon as we hit 1,000 fans. (So click "like" if you want a chance to win!)
Why are a bunch of Miami attorneys doing a free iPad giveaway?
In all honesty -- and this is the only truthful answer we could give you -- we want to get our name out there as far and wide as possible. What business doesn't? And Facebook is a great way to do that.
Plus, we can't think of many devices on the market today that are better than the iPad. Tablet computing is steadily improving and many lawyers are beginning ...
Persons who have tested positive for herpes simplex virus type 2 (HSV-2) but do not have symptoms or genital lesions still experience virus shedding during subclinical (without clinical manifestations) episodes, suggesting a high risk of transmission from persons with unrecognized HSV-2 infection, according to a study in the April 13 issue of JAMA, a theme issue on infectious disease and immunology.
Anna Wald, M.D., M.P.H., of the University of Washington and Fred Hutchinson Cancer Research Center, Seattle, presented the findings of the study at a JAMA media briefing ...
There are differences between adult and pediatric patients regarding the appropriate treatment and prevention efforts for health-care associated infections, highlighting a need for pediatric-specific quality measures to guide infection prevention and treatment practices, according to a commentary in the April 13 issue of JAMA, a theme issue on infectious disease and immunology.
Camille Sabella, M.D., of the Cleveland Clinic Children's Hospital, presented the commentary at a JAMA media briefing at the National Press Club in Washington, D.C.
Dr. Sabella and commentary ...
In a callous political move, Governor Cuomo dealt a significant blow to the rights of brain damaged children to help offset the State's budget shortfall. Shortly after this election, the Governor appointed a Committee to review medical malpractice cases. The committee consisted of medical-hospital-insurance representatives. There was no one to speak for neurologically impaired infants. The Committee recommended and the Governor pushed the Legislature to pass, and he immediately signed, a bill establishing a "Neurologically Impaired Infant Medical Indemnity Fund".
As ...
Bacterial genes that make urine less acidic could be good targets to prevent catheter blockage, according to research presented at the Society for General Microbiology's Spring Conference in Harrogate. The findings could lead to new strategies to prevent serious infections, particularly in long-term catheterization patients.
Urinary catheters are devices used in hospitals and community care homes to manage a range of bladder conditions, and are commonly used to manage incontinence in elderly individuals for long periods of time. Scientists from the University of Brighton, ...
Manuka honey could be an efficient way to clear chronically infected wounds and could even help reverse bacterial resistance to antibiotics, according to research presented at the Society for General Microbiology's Spring Conference in Harrogate.
Professor Rose Cooper from the University of Wales Institute Cardiff is looking at how manuka honey interacts with three types of bacteria that commonly infest wounds: Pseudomonas aeruginosa, Group A Streptococci and Meticillin-resistant Staphylococcus aureus (MRSA). Her group has found that honey can interfere with the growth ...
ANN ARBOR, Mich. — Researchers at the University of Michigan Health System have uncovered a new link between genetic variations associated with alcoholism, impulsive behavior and a region of the brain involved in craving and anxiety.
The results, published online April 12 in Molecular Psychiatry, suggest that variations in the GABRA2 gene contribute to the risk of alcoholism by influencing impulsive behaviors, at least in part through a portion of the cerebral cortex known as the insula, says study senior author Margit Burmeister, Ph.D., research professor at U-M's Molecular ...
On the off chance that any of my Wealth Counsel colleagues from warmer climes are unaware of conditions in the Midwest, southeast Michigan in mid-February is not full of sun and ripe for delightful outdoor activities (I've shocked you, I'm sure). Some people from our wonderful state enjoy all that our winters have to offer, including skiing, snowboarding and snowmobiling. Our law practice, however, has a significant number of retirement-age clients, and for those clients, and for the rest of us who prefer to reserve our outdoor recreation for the warmer months, February ...
EDITOR'S PICK
Protein could improve recovery from heart attacks
Angiogenesis, the development of new blood vessels, is required during embryonic development and wound healing, as well as during disease processes such as tumor growth. The signals that direct angiogensis are incompletely understood, but could represent novel targets for the development of therapies that promote or inhibit this process.
In this paper, Young-Guen Kwon and colleagues, of Yonsei University in Seoul, Korea, investigated the role of two related proteins- DKK1 and DKK2- in angiogenesis. These ...
